MTOR and nonpapillary renal cell carcinoma: A comprehensive understanding of the AKT-mTOR pathway and associated lipid metabolism in ccRCC could enhance our knowledge of intricate cellular regulation, thereby establishing a robust foundation for novel therapeutic strategies.